Want to see KR:271980 full AI Analyst Report?
Jeil Pharmaceutical Co. Ltd. (271980) Financial Statements
Jeil Pharmaceutical Co. Ltd. Financial Overview
Jeil Pharmaceutical Co. Ltd.'s market cap is currently ₩126.77B. The company's EPS TTM is ₩1215.67; its P/E ratio is 6.85; and it has a dividend yield of 0.30%. Jeil Pharmaceutical Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₩ 566.34B | ₩ 704.54B | ₩ 726.39B | ₩ 722.23B | ₩ 700.69B |
| Gross Profit | ₩ 208.38B | ₩ 177.49B | ₩ 184.26B | ₩ 156.80B | ₩ 155.98B |
| Operating Income | ₩ 20.33B | ₩ -18.93B | ₩ 8.73B | ₩ -13.50B | ₩ -10.39B |
| EBITDA | ₩ 32.65B | ₩ -10.61B | ₩ 17.72B | ₩ -1.21B | ₩ -2.02B |
| Net Income | ₩ 23.38B | ₩ -29.97B | ₩ 5.00B | ₩ -13.09B | ₩ -12.47B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₩ 58.83B | ₩ 57.46B | ₩ 35.66B | ₩ 31.59B | ₩ 28.00B |
| Total Assets | ₩ 510.57B | ₩ 525.70B | ₩ 487.33B | ₩ 456.89B | ₩ 426.49B |
| Total Debt | ₩ 93.42B | ₩ 75.70B | ₩ 71.17B | ₩ 50.35B | ₩ 47.80B |
| Net Debt | ₩ 44.54B | ₩ 22.22B | ₩ 38.18B | ₩ 18.90B | ₩ 14.39B |
| Total Liabilities | ₩ 259.55B | ₩ 306.38B | ₩ 330.29B | ₩ 301.29B | ₩ 259.14B |
| Stockholders' Equity | ₩ 211.07B | ₩ 188.15B | ₩ 158.57B | ₩ 157.91B | ₩ 168.21B |
| Cash Flow | |||||
| Free Cash Flow | ₩ -13.72B | ₩ -3.40B | ₩ -14.56B | ₩ -32.11B | ₩ 13.71B |
| Operating Cash Flow | ₩ -5.69B | ₩ 3.21B | ₩ -4.98B | ₩ -15.15B | ₩ 19.10B |
| Investing Cash Flow | ₩ -15.34B | ₩ -7.30B | ₩ -11.92B | ₩ -12.92B | ₩ -8.04B |
| Financing Cash Flow | ₩ 17.05B | ₩ 23.06B | ₩ 18.77B | ₩ 33.62B | ₩ 11.07B |
Currency in KRW
